Read the latest headlines about the Viennese and Austrian health and pharmaceuticals industry
Sponsored
Page 2/2

Vienna International Health and Pharmaceutical Industry News

Record Sales for VAMED AG

The Austrian health care group was able to increase sales and EBIT by 15%. Orders on hand at over € 800m are record high.

March 25, 2011 · Updated: March 25, 2011; 03:24

Lannacher has Delivery Problems with Iodine Tablets

The Austrian pharmaceutical company manufactures the only potassium iodide tablets in the German-speaking area. Demand strongly exceeds production capacity.

March 18, 2011

Opportunities for Austrian Medical Technology in the UK

An Austrian study showed Austrian buinesses the opportunities offered by the British market: Austrian exports increased by 15% in 2010.

March 17, 2011

Massive Losses for Intercell

The Austrian pharmaceutical company today reported losses for 2010 amounting to € 255m. Operating cash flow has been strongly negative too.

March 2, 2011

Intercell Issues Convertible Bond

The Austrian pharmaceutical company Intercell starts offering of € 30.8m senior convertible debt financing.

February 23, 2011

Sanochemia: Strong Increase in EBIT

The Austrian pharmaceutical company today announced its figures for Q1. Earnings rise eight-fold.

February 18, 2011

Sanochemia Stays in the Red

Despite improvements in its financial data, the Austrian pharmaceutical company Sanochemia does not succeed in eliminating its losses

January 28, 2011

Humanomed to Expand to CEE/SEE

The Austrian Humanomed-Group, a health care company, sees potential to expand to countries in (South) Eastern Europe.

January 28, 2011

Sanochemia Takes Over Alvetra & Werfft

The Austrian pharmaceutical company Sanochemia strengthens its market position through the acquisition of Alvetra & Werfft GmbH.

January 25, 2011

Pfizer Austria: First Sustainability Report Published

Pfizer Austria published its first sustainability report based on the recognized guidelines of the Global Reporting Initiative.

January 20, 2011

Sanochemia: Decrease in Sales, Decrease in Losses

The Vienna Stock Exchange listed manufacturer of pharmaceutical products could improve its results slighty.

January 3, 2011

Intercell Raises Authorized Capital

The Management Board of the Austrian biotechnology company is authorized to increase the share capital up to a nominal amount of € 855,000.00.

December 16, 2010

Serious setback for Intercell

The Vienna vaccine manufacturers has to terminate a research project unexpectedly at a late stage. Heavy losses are expected for this year.

December 14, 2010

Economic Chamber in Tokyo: Biotechnology as an Opportunity

The President of the Vienna Economic Chamber, Brigitte Jank, sees above all great opportunities for Austria in Japanese biotechnology and pharmaceutical industries.

December 6, 2010

Expansion Potential of Austrian Pharmaceutical Industry in Japan

Japanese pharmaceutical companies need new products and international cooperation. An opportunity for local companies.

December 1, 2010

F-Star Acquired Major Order

The Vienna-located f-star and Boehringer Ingelheim to collaborate in discovery and development of therapeutic antibodies.

November 23, 2010

Roche Lays Off 400 Jobs in Styria

The Swiss pharmaceutical group reduces its international workforce by 6%: a setback for the region.

November 18, 2010

Intercell AG: Losses Doubled, Positive Outlook

Today, Vienna-based Intercell AG announced its financial results for the third quarter of 2010 and presented changes to the Management Board.

November 9, 2010

Coface CEE Top 500 - Poland Largest Number of Companies in CEE

Poland has the largest number of companies in the Central and Eastern Europe Top 500 with 28.4%. Hungary ranks second with 16.6%, overtaking the Czech Republic, which is home for 13.8% of the CEE Top 500.

October 12, 2010

Vienna now has its own Expat Center

In Vienna, the first Expat Center in Austria was opened. The project was handled by the Vienna Business Agency (former WWFF).

September 30, 2010

Humanomed Takes Over Management of Private Clinics in the CEE Region

The know-how of the private clinic operator is to be exported. The objective is not to only give advice, but also to take over the management of private clinics in the CEE region.

September 28, 2010

Insolvencies: Declining Trend for Both Companies and Individuals

KSV expects 10% less insolvencies for 2010, but warns about the consequences of fiscal budget adjustment.

September 28, 2010

Austria Continues Being the Largest Investor in Romania

"Romania is an important market in Eastern Europe for the Austrian economy. Its great importance for us is proved by the fact that Austria is by far the largest investor in Romania"

September 23, 2010

Austria's Management and Supervisory Boards’ Salaries on the Test Bench

The partly state-run OMV had the most expensive board of all Austrian corporations in 2009. In total, the oil company spent 10.2 million euro on its bosses, 23.4% more than the previous year.

September 20, 2010

Intercell reports Phase II Study Results of its Vaccine Enhancement Patch for Pandemic Influenza

Intercell AG today announced the results of a Phase II clinical trial of its investigational Vaccine Enhancement Patch (VEP) system for avian H5N1 influenza.

July 2, 2010

Siemens Austria wins award for research project

The research project Reconcile was awarded as best proposal for the funding program FIT-IT (Tesearch, Innovation, technology, information technology) in the program series "Semantic Systems and Services".

June 23, 2010

Wolfgang Hesoun is new head of Siemens - Porr boss succeeds Brigitte Ederer

On Wednesday the Supervisory Board of Siemens Austria will decide on the new head of the company.

June 15, 2010

Siemens VAI Expands in China and India

Upper Austrian Siemens VAI wants to radically expand its activities in China and India.

May 25, 2010

Intercell AG - Hospital bug vaccine delayed

According to an announcement by Zoe Schneeweiss and Namoi Kresge (Bloomberg) Intercell AG fell the most in two weeks in Vienna, after stating that a vaccine against a deadly hospital bug may be delayed to the first or second quarter of 2011.

May 18, 2010

Austrian health insurance sector recorded a small deficit

After last year’s surplus Austria’s 19 health insurance companies are expecting a minor deficit in 2010. According to May’s forecast a €11.8m decline is expected at an overall budget of 14.5 billion euros.

May 17, 2010